TherapeuticsMD, Inc. — Director's Dealing 2011

Oct 11, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (AMHND)
CIK: 0000025743
Period of Report: 2011-10-04

Reporting Person: Bernick Brian (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9119767	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified Stock Option	$0.1018	2019-01-01	Common Stock (1472910)		Indirect
Common Stock Purchase Warrant	$0.4074	2021-06-06	Common Stock (61372)		Indirect

Footnotes

F1: Option vests at the rate of 40,914 shares per month over the three years from the date of issuance. Shares vested to date are 1,391.062. This option was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.

F2: Warrant vested on issuance. This warrant was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.